Faculty

and/or
30 Faculty members found
The Ingo Mellinghoff Lab
Human Oncology & Pathogenesis Program
Ingo K. Mellinghoff, MD, FACP
Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.
Human Oncology & Pathogenesis Program
Ivan Maillard, MD, PhD
New roles for Notch signaling in the immune system.
The James Fagin Lab
Human Oncology & Pathogenesis Program
James A. Fagin, MD
Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.
Human Oncology & Pathogenesis Program
Joe Chan, MD, PhD
Memorial Hospital Research Laboratories
Jonathan Peled, MD, PhD
The Peled lab focuses on cancer immunotherapy.
Immuno-Oncology Program
Juan C. Osorio, MD
The Osorio Lab studies the mechanisms of antibody-mediated immunity, with a focus on myeloid cell reprograming to advance cancer immunotherapies.
Human Oncology & Pathogenesis Program
Megan S. Lim, MD, PhD
Physician-scientist Megan Lim studies the molecular pathogenesis of lymphoma.
Human Oncology & Pathogenesis Program
Kojo S. Elenitoba-Johnson, MD
We leverage large-scale unbiased profiling including genomics, transcriptomics, proteomics to identify candidate oncogenes and proteins that are pathogenetically relevant in lymphoma.
The Liang Deng Lab
Memorial Hospital Research Laboratories
Liang Deng, MD, PhD
Physician-scientist Liang Deng studies poxvirus interface with the immune system and the development of poxviruses as oncolytic and immunotherapy for cancers.
Ladanyi lab
Human Oncology & Pathogenesis Program
Marc Ladanyi, MD
Molecular pathologist Marc Ladanyi studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma.